Literature DB >> 25805806

A new era of secreted phospholipase A₂.

Makoto Murakami1, Hiroyasu Sato2, Yoshimi Miki2, Kei Yamamoto2, Yoshitaka Taketomi2.   

Abstract

Among more than 30 members of the phospholipase A2 (PLA2) superfamily, secreted PLA2 (sPLA2) enzymes represent the largest family, being Ca(2+)-dependent low-molecular-weight enzymes with a His-Asp catalytic dyad. Individual sPLA2s exhibit unique tissue and cellular distributions and enzymatic properties, suggesting their distinct biological roles. Recent studies using transgenic and knockout mice for nearly a full set of sPLA2 subtypes, in combination with sophisticated lipidomics as well as biochemical and cell biological studies, have revealed distinct contributions of individual sPLA2s to various pathophysiological events, including production of pro- and anti-inflammatory lipid mediators, regulation of membrane remodeling, degradation of foreign phospholipids in microbes or food, or modification of extracellular noncellular lipid components. In this review, we highlight the current understanding of the in vivo functions of sPLA2s and the underlying lipid pathways as revealed by a series of studies over the last decade.
Copyright © 2015 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  arachidonic acid; eicosanoids; fatty acid; immunology; inflammation; lipidomics; lysophospholipid; membranes; obesity; phospholipids/metabolism

Mesh:

Substances:

Year:  2015        PMID: 25805806      PMCID: PMC4479330          DOI: 10.1194/jlr.R058123

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  165 in total

1.  Cloning and recombinant expression of a novel mouse-secreted phospholipase A2.

Authors:  E Valentin; R S Koduri; J C Scimeca; G Carle; M H Gelb; M Lazdunski; G Lambeau
Journal:  J Biol Chem       Date:  1999-07-02       Impact factor: 5.157

2.  Otoconin-90, the mammalian otoconial matrix protein, contains two domains of homology to secretory phospholipase A2.

Authors:  Y Wang; P E Kowalski; I Thalmann; D M Ornitz; D L Mager; R Thalmann
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

3.  Induction of ectopic olfactory structures and bone morphogenetic protein inhibition by Rossy, a group XII secreted phospholipase A2.

Authors:  Ignacio Muñoz-Sanjuán; Ali H Brivanlou
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

4.  Protection by group II phospholipase A2 against Staphylococcus aureus.

Authors:  V J Laine; D S Grass; T J Nevalainen
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

5.  Circulating levels of secretory type II phospholipase A(2) predict coronary events in patients with coronary artery disease.

Authors:  K Kugiyama; Y Ota; K Takazoe; Y Moriyama; H Kawano; Y Miyao; T Sakamoto; H Soejima; H Ogawa; H Doi; S Sugiyama; H Yasue
Journal:  Circulation       Date:  1999-09-21       Impact factor: 29.690

6.  Neuronal expression and neuritogenic action of group X secreted phospholipase A2.

Authors:  Seiko Masuda; Makoto Murakami; Yasukazu Takanezawa; Junken Aoki; Hiroyuki Arai; Yukio Ishikawa; Toshiharu Ishii; Manabu Arioka; Ichiro Kudo
Journal:  J Biol Chem       Date:  2005-03-21       Impact factor: 5.157

7.  Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2.

Authors:  B Ivandic; L W Castellani; X P Wang; J H Qiao; M Mehrabian; M Navab; A M Fogelman; D S Grass; M E Swanson; M C de Beer; F de Beer; A J Lusis
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-05       Impact factor: 8.311

8.  Regulation of type V phospholipase A2 expression and function by proinflammatory stimuli.

Authors:  H Sawada; M Murakami; A Enomoto; S Shimbara; I Kudo
Journal:  Eur J Biochem       Date:  1999-08

9.  Roles of Trp31 in high membrane binding and proinflammatory activity of human group V phospholipase A2.

Authors:  S K Han; K P Kim; R Koduri; L Bittova; N M Munoz; A R Leff; D C Wilton; M H Gelb; W Cho
Journal:  J Biol Chem       Date:  1999-04-23       Impact factor: 5.157

10.  Expression and characterization of human group V phospholipase A2.

Authors:  Y Chen; E A Dennis
Journal:  Biochim Biophys Acta       Date:  1998-10-02
View more
  71 in total

1.  Is iPLA2β a Novel Target for the Development of New Strategies to Alleviate Inflammatory Bowel Disease?

Authors:  Toni Petan; Igor Križaj
Journal:  Dig Dis Sci       Date:  2015-12       Impact factor: 3.199

2.  Introduction to Thematic Review Series: Phospholipases: Central Role in Lipid Signaling and Disease.

Authors:  Edward A Dennis
Journal:  J Lipid Res       Date:  2015-06-01       Impact factor: 5.922

Review 3.  The Molecular Basis of Toxins' Interactions with Intracellular Signaling via Discrete Portals.

Authors:  Adi Lahiani; Ephraim Yavin; Philip Lazarovici
Journal:  Toxins (Basel)       Date:  2017-03-16       Impact factor: 4.546

Review 4.  Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators.

Authors:  Charles N Serhan; Bruce D Levy
Journal:  J Clin Invest       Date:  2018-05-14       Impact factor: 14.808

5.  Activity-based targeting of secretory phospholipase A2 enzymes: A fatty-acid-binding-protein assisted approach.

Authors:  Amir Keshavarz; Ligia Zelaya; Jasmeet Singh; Radha Ranganathan; Joseph Hajdu
Journal:  Chem Phys Lipids       Date:  2016-11-25       Impact factor: 3.329

6.  Alterations in Epidermal Eicosanoid Metabolism Contribute to Inflammation and Impaired Late Differentiation in FLG-Mutated Atopic Dermatitis.

Authors:  Stefan Blunder; Ralph Rühl; Verena Moosbrugger-Martinz; Christine Krimmel; Anita Geisler; Huiting Zhu; Debra Crumrine; Peter M Elias; Robert Gruber; Matthias Schmuth; Sandrine Dubrac
Journal:  J Invest Dermatol       Date:  2016-10-26       Impact factor: 8.551

7.  Group V secreted phospholipase A2 plays a protective role against aortic dissection.

Authors:  Kazuhiro Watanabe; Yoshitaka Taketomi; Yoshimi Miki; Kiyotaka Kugiyama; Makoto Murakami
Journal:  J Biol Chem       Date:  2020-06-01       Impact factor: 5.157

8.  Epigenetic control of group V phospholipase A2 expression in human malignant cells.

Authors:  Mario Menschikowski; Albert Hagelgans; Brit Nacke; Carsten Jandeck; Olga A Mareninova; Liana Asatryan; Gabriele Siegert
Journal:  Tumour Biol       Date:  2015-12-29

9.  Antimalarial Activity of Human Group IIA Secreted Phospholipase A2 in Relation to Enzymatic Hydrolysis of Oxidized Lipoproteins.

Authors:  Mélanie Dacheux; Véronique Sinou; Christine Payré; Louise Jeammet; Daniel Parzy; Philippe Grellier; Christiane Deregnaucourt; Gérard Lambeau
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

10.  Development of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulations.

Authors:  Sofia Vasilakaki; Efrosini Barbayianni; Georgios Leonis; Manthos G Papadopoulos; Thomas Mavromoustakos; Michael H Gelb; George Kokotos
Journal:  Bioorg Med Chem       Date:  2016-03-02       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.